KIMS QIP 2026: 19.87m shares at ₹755, issue closes

What KIMS announced

Krishna Institute of Medical Sciences Ltd (KIMS) said it has closed its Qualified Institutions Placement (QIP) on June 19, 2026. The company allotted 19,867,549 equity shares to eligible qualified institutional buyers. The issue price was fixed at ₹755 per share. KIMS said the Finance and Investment Committee approved the closure and allotment after receipt of funds from the investors. The fundraise was positioned as a primary issuance of shares.

Allotment details and issue size

The allotment price of ₹755 per share includes a premium of ₹753 per equity share over the face value. The face value of each equity share is ₹2. Based on the allotted shares and issue price, the QIP works out to nearly ₹1,500 crore in gross proceeds. The placement document reviewed by Mint had indicated the company intended to raise up to ₹1,500 crore through this issuance. KIMS also indicated the offer size was up to about 19.86 million new shares.

Issue timeline and approvals

The QIP opened on June 16, 2026 and closed on June 19, 2026. The Finance and Investment Committee met on June 19 to approve the closure of the issue period and to finalise the allocation. KIMS had taken enabling approvals earlier in the year. The board approved the proposal on March 11, 2026. Shareholders provided consent through a postal ballot on April 15, 2026.

How the QIP price was set

KIMS disclosed a floor price of ₹771.73 per share for the QIP. The final issue price of ₹755 reflects a discount of ₹16.73 per share, which the company said equals 2.17% of the floor price. KIMS said the committee determined the issue price in consultation with the book running lead managers. The company cited Regulation 176(1) under Chapter VI of the SEBI ICDR Regulations for computing the floor price and applying the permitted discount. Mint’s report also described ₹755 as an indicative placement price and noted it represented a 3.04% discount to the day’s closing price of ₹778.65 on the National Stock Exchange.

Where KIMS plans to use the money

KIMS stated that proceeds will be used primarily for repayment or prepayment of outstanding borrowings of the parent entity and its subsidiaries. Of the total amount being raised, ₹910 crore is earmarked to clear the debt of the listed entity. Another ₹215 crore is meant for debt clearance in subsidiaries Chalasani Hospitals Pvt. Ltd, KIMS Hospitals Pvt. Ltd, and KIMS Hospital Bengaluru Pvt. Ltd. The remaining funds are to be allocated to general corporate purposes. The stated end-use aligns the equity raise with balance sheet deleveraging.

Lock-up, managers, and trading window rules

The QIP includes a 60-day lock-up agreement for both the company and its promoting shareholders. IIFL Capital and Jefferies India Pvt. Ltd are acting as book-running lead managers. KIMS also disclosed governance-related dealing restrictions for insiders during the process. The trading window for designated persons had been closed since the issue opening. The company said it will reopen 48 hours after determination of the issue price.

What happened to the KIMS share price

KIMS shares were reported around ₹806.75 as on June 19, 2026 at 16:00 IST. The stock’s open was listed at ₹793.35, with a previous close of ₹789.75. An additional price snapshot in the provided information showed ₹793.35 with a move of +₹3.60 (+0.46%). These data points indicate the stock traded above the QIP issue price during the window when the placement was being finalised. The indicative placement price referenced by Mint was also below the market price cited in that report.

Key numbers at a glance

Why the QIP matters for investors

The QIP closes a key capital-raising step that KIMS had been preparing for since its board approval in March and shareholder consent in April. The company has linked the proceeds directly to debt reduction, including borrowings at both the listed entity and certain subsidiaries. Investors will track how the reduction in borrowings progresses, given the specific allocation of ₹910 crore and ₹215 crore for debt clearance. The discount to the floor price and the reference discount to the prevailing market price are standard features of institutional placements, but they also set a public benchmark for the new issuance. Mint’s report also noted that listing of the primary shares was expected on or around June 25, following pricing.

Conclusion

KIMS has completed its QIP allotment on June 19, 2026, issuing 19.87 million shares at ₹755 per share under SEBI ICDR and Companies Act provisions. The company has outlined a clear use of funds focused on repaying and prepaying borrowings, with the balance for general corporate purposes. With the issue now closed and funds received, the next operational milestones are the reopening of the trading window for designated persons and the expected listing of the new shares around June 25, as referenced in the placement timeline.